U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
BAFISONTAMAB
INN  
Official Name English
ANTI-EGFR/C-MET BISPECIFIC ANTIBODY EMB-01
Common Name English
EMB-01
Code English
IMMUNOGLOBULIN G1, BISPECIFIC, ANTI-(HUMAN HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET) (HUMAN .KAPPA.-CHAIN) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR) (HUMAN .GAMMA.1-CHAIN), DISULFIDE WITH IMMUNOGLOBULIN G1 ANTI-(H
Common Name English
EMB01
Common Name English
FIT-013A
Common Name English
ANTI-EGFR/ANTI-C-MET BISPECIFIC ANTIBODY EMB-01
Common Name English
bafisontamab [INN]
Common Name English
Code System Code Type Description
NCI_THESAURUS
C158085
Created by admin on Sat Dec 16 14:47:51 GMT 2023 , Edited by admin on Sat Dec 16 14:47:51 GMT 2023
PRIMARY NCIT
FDA UNII
G86X5QQ7M5
Created by admin on Sat Dec 16 14:47:51 GMT 2023 , Edited by admin on Sat Dec 16 14:47:51 GMT 2023
PRIMARY
INN
11851
Created by admin on Sat Dec 16 14:47:51 GMT 2023 , Edited by admin on Sat Dec 16 14:47:51 GMT 2023
PRIMARY
CAS
2437210-79-0
Created by admin on Sat Dec 16 14:47:51 GMT 2023 , Edited by admin on Sat Dec 16 14:47:51 GMT 2023
PRIMARY
ACTIVE MOIETY
BAFISONTAMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966